Ease of Use.

“Given IRO’s ability to provide continuous monitoring of cell culture, its automated and sterile cell/ culture additions, as well as its demonstrated efficiency with producing large amount of CAR+ T-cells, it is [our] Process Development opinion that the IRO bioreactor has potential to streamline the T-cell Therapy space”